english.prescrire.org > Topics > Advancing healthcare policy > Advancing healthcare policy in Europe: a chronological recap of actions > 2017 Recap > No to EMA's provision of confidential scientific advice to drug companies (11/2017)

Advancing healthcare policy

Advancing healthcare policy in Europe: a chronological recap of actions

A recap of actions in 2017
No to EMA's provision of confidential scientific advice to drug companies (November 2017)

Paris, 28 November 2017

Prescrire, along with around 20 civil society organisations, has signed a joint declaration drawing attention to potential problems posed by the provision of confidential scientific advice by the European Medicines Agency to pharmaceutical companies, especially a decline in regulatory standards, a risk of institutional capture, and a total lack of transparency surrounding the activity of European regulatory authorities.

> Click here to download the joint declaration (413 Ko)


©Prescrire November 2017